ArticleJACC. Case reports2025
QT Prolongation and Ventricular Pre-Excitation in Psychiatric Illness: Have We Pre-Excited our Colleagues?
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
clinical conditionA 27-year-old male patient presented with acute psychosis complicated by a prolonged corrected QT (QTc) interval in the setting of Wolff-Parkinson-White (WPW) pattern. The patient required antipsychotic medications that are high risk for prolonging the QTc interval and putting the patient at risk for torsades de pointes (TdP). KEY QUESTIONS: The key questions were as follows: 1) How does WPW affect the QTc interval? 2) Does the prolongation of the QTc interval seen in pre-excitation confer increased risk for TdP? and 3) How should patients with WPW and psychiatric illnesses be risk stratified when considering pathway ablation? OUTCOME: Early cardiology involvement allowed safe, early antipsychotic medication initiation. A multidisciplinary team approach resulted in a strategy of early catheter ablation because of the risk for pre-excited atrial fibrillation during future electroconvulsive therapy. TAKE-HOME MESSAGE: Despite broad awareness of the relationship between a prolonged QT interval and TdP, QT prolongation does not always reflect primary ventricular abnormalities that predispose to TdP, allowing the safe administration of antipsychotic agents in patients who need them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.